Aging in haemophilia: getting to the heart of the matter.

نویسنده

  • Margaret V Ragni
چکیده

As a result of safer blood products and more effective treatments for human immunodeficiency virus (HIV) and hepatitis C infection (HCV), the life expectancy of those with haemophilia is approaching that of the general population. This was predicted over 20 years ago by Dutch epidemiologists who assessed the mortality of haemophilic men, after controlling for HIV and HCV infections (1). Thus, if trends in haemophilia follow the world population, 20% will be over 60 years of age by the year 2050 (2). To meet the challenges of the aging haemophilia population, it will be critical to plan for the treatment and prevention of diseases previously uncommon in haemophilia, but not uncommon in the general population, chief among which is the major cause of morbidity and mortality in Western society, atherosclerotic heart disease (ASHD). This may seem counter-intuitive, given the well-known 50% to 80% lower ASHD mortality in men with haemophilia than in the general population (1, 3, 4). The protection against ASHD mortality is attributed to hypocoagulability, that is, low factor VIII or IX, which reduces thrombus formation on a ruptured atherosclerotic plaque and fatal myocardial infarction (5, 6). Yet, whether hypocoagulability is protective against development of ASHD the disease, and whether ASHD will increase as the haemophilia population ages is controversial. What is the evidence that haemophilic men may be at risk for ASHD? At a molecular level, atherosclerosis is a chronic inflammatory response directed at the arterial wall, at specific sites where fatty streaks have progressed to lipid plaques, with lipid accumulation in macrophages, so-called macrophage foam cells, and foam cell trapping within the arterial intima (2, 7). In animal models, in fact, it is mice deficient in regulators of lipid trafficking, not those with haemophilia or von Willebrand disease, that are protected against atherosclerosis. Specifically, hyperlipidaemic mice deficient in CD36, a scavenger receptor that modulates migration of macrophages and traps oxidised LDL in arterial intima (2), are protected from lipid atheroma, but atherosclerotic-prone apolipoprotein E – factor VIII knockout mice (8) and pigs with von Willebrand disease (9) develop atherosclerotic plaques indistinguishable from unaffected animals. Thus, hypocoagulability in animals does not appear to protect against ASHD. Is this true for the aging man with haemophilia? Evidence has been increasing that both atherosclerosis and atherosclerotic risk factors are not uncommon or new in haemophilia. First, the frequency of pathogenic coronary atherosclerosis was recently shown to be similar to that in the general population. In an autopsy study of men with haemophilia, most of whom died of HIV or hepatitis, the degree of intraluminal coronary stenosis was similar to that in age-, sex-, race-matched controls (10). Cardiovascular risk factors, including hypertension, smoking, diabetes, and hyperlipidaemia, in those cases were similar to controls (10). These findings were further supported by a statewide analysis of inpatient ASHD discharge data in haemophilic men showing disease prevalence and cardiovascular risk factors are similar to controls (11). Further, a six-state CDC (Centres for Disease Control) study of hospitalised haemophilic men found that 15% over age 60 had ischaemic heart disease, independently associated with traditional risk factors, as well as factor infusion and HIV disease Correspondence to: Margaret V. Ragni, MD, MPH University of Pittsburgh, Department of Medicine Division Hematology/Oncology Director, Haemophilia Center of Western PA 3636 Boulevard of the Allies Pittsburgh, PA 15213–4306, USA Tel.: +1 412 209 7288, Fax: +1 412 209 7281 E-mail: [email protected]

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

حیات آثار تاریخی معماری ایرانی (مقایسه‌ی تطبیقی کهولت اثر تاریخی با سالخوردگی در دیدگاه اسلام)

Getting older in every existence (animate beings and inanimate objects) cusses a quality, which could be called senescence. Physical appearance of senescence results in internal challenge, change and development. In order to improve a correct interaction between human and historical site, it is necessary to study the unknown capacities of Iranian historical architecture. Compared with the physi...

متن کامل

Klotho as a Novel Cardioprotective Protein in Aged Heart

 In recent years, researchers have been looking for genes whose products can directly affect the aging process. Among these, the anti-aging protein klotho has attracted much attention. This single transmembrane protein is expressed in the renal tissues, parathyroid gland and choroid network of the brain and acts as a co-receptor for Fibroblast Growth Factor FGF. In this way, it contributes to c...

متن کامل

Effect of high intensity interval and continuous endurance training on TRF2 and TERT gene expression in heart tissue of aging male rats

Background and Objective: Age is the greatest risk factor for cardiovascular disease that is associated with shortens telomere. TRF2 and TERT genes expression in heart tissue   reduce in elderly. These geness are associated with shortens telomere. Exercise can play a useful role in maintaining the length of telomeres. This study was carry out to determine the effect of high intensity interval t...

متن کامل

Effect of high intensity interval training and continus training on antioxidant enzymes in the heart of the old rats

Background and Objective: Aging is associated with increased free radical production. On the other hand, sports activities with the improvement of antioxidant system can reduce the damage caused by aging. This study was performed to determine the effect of the coantinus training (MCT) and high intensity interval training (HIIT) on antioxidant enzymes in the heart of old rats. Methods: This exp...

متن کامل

Evaluation of inhibitor antibodies in haemophilia A population

Background: Inhibitory antibody to exogenous Factor VIII (FVIII) is a major complication of hemophilia treatment. This study was conducted to determine the prevalence of inhibitor antibody directed against FVIII.Methods: From May 2010 to May 2011, 52 patients with severe hemophilia A admitted in Amirkola Children’s Hospital were evaluated. Those who had abnormal mixing study, antibody against F...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Thrombosis and haemostasis

دوره 105 2  شماره 

صفحات  -

تاریخ انتشار 2011